Loading clinical trials...
Loading clinical trials...
Impact of an Echographic Algorithm on Hemodynamic Optimization in the First 4 Days of Septic Shock Management: a Multicentric, Randomized, Controlled, Open Label Pilot-study
Fluid management is one of the key issues in the initial management of septic shock (SS). Fluid overload and hypovolemia have been associated with increased mortality in several trials. Transthoracic echocardiography (TTE) and lung ultrasound are recommended for haemodynamic assessment in critically ill patients. However, the benefit of hemodynamic optimisation using echography has not been yet evaluated. The purpose of this multicenter, controlled, randomized trial is to assess the impact of an echocardiographic algorithm of hemodynamic optimization on fluid management in septic patients during the first 4 days of therapy.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
CHU de Nimes
Nîmes, France
Start Date
February 8, 2024
Primary Completion Date
September 26, 2024
Completion Date
October 26, 2024
Last Updated
March 15, 2024
136
ESTIMATED participants
Echographic hemodynamic algorithm guiding fluid resuscitation
OTHER
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
NCT04972526
NCT06263075
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions